Bradycardia and asystole following the rapid administration of sufentanil with vecuronium.
Starr
N J
NJ
Sethna
D H
DH
Estafanous
F G
FG
D000777:Anesthetics / Q000008:administration & dosage / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D001794:Blood Pressure / Q000187:drug effects; D001919:Bradycardia / Q000139:chemically induced*; D004338:Drug Combinations; D005283:Fentanyl / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006323:Heart Arrest / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009466:Neuromuscular Blocking Agents / Q000008:administration & dosage / Q000009:adverse effects*; D010197:Pancuronium / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D017409:Sufentanil; D014673:Vecuronium Bromide
D000777:Anesthetics; D004338:Drug Combinations; D009466:Neuromuscular Blocking Agents; D014673:Vecuronium Bromide; D017409:Sufentanil; D010197:Pancuronium; D005283:Fentanyl